Traditionally, therapeutic discovery has focused on minute agents, but peptide collaborations are progressively receiving momentum. This new strategy utilizes combining short amino acid chains with alternative therapeutic techniques to address complex condition mechanisms. By utilizing the specific characteristics of peptides – such as substantia